{
    "title": "109_hr1378",
    "content": "The Act may be cited as the \"Ephedrine Alkaloids Regulation Act of 2005\". The Congress recognizes the increasing danger of methamphetamine trafficking, production, and abuse in the United States. Methamphetamine is highly addictive and easily made from store-bought products. The prevalence of step-by-step recipes on the Internet has led to a rise in clandestine labs. These labs pose a significant threat to public health and safety due to the toxic and unstable chemicals involved in methamphetamine production. Methamphetamine production has spread from the West Coast to the Midwest and East Coast, particularly in New York and Florida. Methamphetamine abuse affects individuals of all ages, socioeconomic levels, and races. Efforts to restrict access to pseudoephedrine, a key ingredient in methamphetamine production, have been ineffective. As methamphetamine production spreads across the country, efforts to restrict access to pseudoephedrine have been ineffective. Pseudoephedrine in liquid forms is not used in methamphetamine production. Congress should establish a uniform standard for distributing pseudoephedrine in tablet form to combat the issue. Congress should establish a uniform standard for distributing pseudoephedrine in tablet form to combat methamphetamine production, including adding ephedrine alkaloids and phenylpropanolamine to Schedule V. Effective 30 days after enactment, ephedrine alkaloids, including ephedrine and pseudoephedrine, and phenylpropanolamine will be listed in schedule V of controlled substances. The Attorney General has the authority to designate substances as controlled. The Controlled Substances Act designates substances like pseudoephedrine and phenylpropanolamine as controlled substances or listed chemicals, except when contained in liquid or gel form in drugs lawfully marketed in the US under the Federal Food, Drug, and Cosmetic Act. Regulation of transactions involving listed chemicals; exemption for certain dosage forms and quantities of pseudoephedrine or phenylpropanolamine. The Controlled Substances Act is amended to redefine regulated transactions involving pseudoephedrine or phenylpropanolamine products in liquid or gel form, with the quantity limit increased to any amount exceeding 9.0 grams. Additionally, the Act is amended to redefine ordinary over-the-counter pseudoephedrine or phenylpropanolamine products. The Controlled Substances Act is amended to redefine regulated transactions involving pseudoephedrine or phenylpropanolamine products in liquid or gel form, with the quantity limit increased to any amount exceeding 9.0 grams. Additionally, amendments are made regarding chemical mixtures not easily used in illicit production."
}